PharmD · Louisiana

Collaborative Practice Agreement for Pharmacists in Louisiana

Yes, a written physician agreement is required. Louisiana calls it a Collaborative Drug Therapy Management (CDTM) Order Set.

Practice authoritySupervision required
Written agreementAgreement required
What Louisiana calls itCollaborative Drug Therapy Management (CDTM) Order Set
Governing boardLouisiana Board of Pharmacy
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Represents Louisiana's pharmacist Collaborative Drug Therapy Management (CDTM) authority, not ordinary licensure — base dispensing and statutory limited authority need no physician agreement and are out of scope here. CDTM is permanently order-set-dependent, with no independence pathway found. Excludes controlled substances and drugs of concern entirely.

What the collaboration must look like

The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.

Proximity

On-site presence required

The pharmacist must 'be geographically located to be physically present to provide pharmacist care' to the patient (LAC 46:LIII.523) — an on-site standard, unusual among the CDTM/CPA frameworks in this dataset, most of which only require telecommunication availability.

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Quarterly

The pharmacist must provide status reports on the patient to the collaborating physician at least quarterly, and remain available through direct telecommunication for consultation (LAC 46:LIII.523).

Prescriptive authority

Covered by the practice agreement · no controlled-substance authority

May not initiate or discontinue drug therapy except as specified in the physician's order set, and may not substitute drugs without explicit written physician consent; controlled substances and 'drugs of concern' are excluded entirely from CDTM scope (LAC 46:LIII.523).

Written agreement

Required

Required, but structured differently than the APRN CPA: Louisiana's CDTM framework uses a per-patient written 'order set' signed by the collaborating physician rather than one standing practice-wide agreement — functionally similar in effect, but not the same document type.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — No confirmed pharmacist-ownership requirement was found for Louisiana pharmacy permits in this research pass — the general national pattern (non-pharmacist/corporate ownership allowed, with a licensed pharmacist-in-charge retaining professional/operational control over dispensing) is assumed by analogy to other states on file, not independently confirmed against Louisiana's Pharmacy Practice Act (R.S. 37:1161 et seq.) text.

Flagged as an unconfirmed inference — verify against the Louisiana Board of Pharmacy's actual permit-ownership rules before relying on this.

Legal sources for these rules (2)
The document: Collaborative Drug Therapy Management (CDTM) Order Set
What a Louisiana Collaborative Drug Therapy Management (CDTM) Order Set must contain, who governs it and who signs: read the Collaborative Drug Therapy Management (CDTM) Order Set page on practiceagreement.com.

What a collaborating physician costs here

Typical monthly cost in Louisiana

$500$600

Estimate for one Pharmacist. Standard-tier state.

About Louisiana's rules

Louisiana remains a 'reduced practice' state for NPs — no SAVE Act-style full-practice-authority reform has passed. LA Admin. Code tit. 46 §7911.A.5 references an hours-based exemption from the CPA requirement for NP/CNM/CNS, but secondary sources give conflicting hour figures (1,000 vs. 2,080) and this pass could not confirm the exact threshold or resulting scope — verify directly with LSBN before relying on it.

Other clinicians in Louisiana: see the state overview.